Sign In
to Vote &
Create Storyboards.
 
Researchers at Columbia University Medical Center say a drug used to treat bone marrow cancer can restore hair for people suffering from alopecia areata. The researchers found ruxolitinib, which already has been approved by the Food and Drug Administration, produced total hair regrowth within five months and the hair persisted after treatment stopped.
6
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard